David Schwartz Selected Research

Squamous Cell Carcinoma (Epidermoid Carcinoma)

1/2019	Outcomes of Adjuvant Radiotherapy Following Negative Surgical Margins for Cutaneous Squamous Cell Carcinoma.
1/2017	The Impact of Adjuvant Postoperative Radiation Therapy and Chemotherapy on Survival After Esophagectomy for Esophageal Carcinoma.
1/2017	Hapten-Anti-Hapten Technique for Two-Color IHC Detection of Phosphorylated EGFR and H2AX Using Primary Antibodies Raised in the Same Host Species.
8/2016	Is There a Benefit to Prolonging the Interval Between Neoadjuvant Chemoradiation and Esophagectomy in Esophageal Cancer?
6/2016	Definitive or Preoperative Chemoradiation Therapy for Esophageal Cancer: Patterns of Care and Survival Outcomes.
11/2015	Application of positron emission tomography/computed tomography in radiation treatment planning for head and neck cancers.
1/2014	Neoadjuvant concurrent chemoradiation for curative treatment of penile squamous cell carcinoma.
2/2010	Impact of postoperative radiation after esophagectomy for esophageal cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

David Schwartz Research Topics

Disease

23	Prostatic Neoplasms (Prostate Cancer) 07/2017 - 12/2010
20	Neoplasms (Cancer) 01/2022 - 02/2008
12	Adenocarcinoma 01/2022 - 02/2010
9	Infections 09/2021 - 06/2003
8	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2019 - 02/2010
7	Crohn Disease (Crohn's Disease) 01/2022 - 04/2018
4	Carcinoma (Carcinomatosis) 01/2022 - 01/2017
4	Fistula 11/2019 - 04/2018
3	Head and Neck Neoplasms (Head and Neck Cancer) 01/2023 - 11/2015
3	Sepsis (Septicemia) 01/2022 - 06/2003
3	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2020 - 11/2007
3	Lung Neoplasms (Lung Cancer) 06/2017 - 01/2009
3	Hemorrhage 01/2017 - 04/2014
3	Esophageal Neoplasms (Esophageal Cancer) 08/2016 - 02/2010
3	Heart Arrest (Cardiac Arrest) 05/2015 - 05/2008
3	Cardiotoxicity 05/2015 - 05/2008
3	Bacteremia 07/2013 - 06/2003
2	Wounds and Injuries (Trauma) 06/2023 - 01/2023
2	Asthma (Bronchial Asthma) 01/2023 - 11/2007
2	Pneumonia (Pneumonitis) 01/2023 - 04/2013
2	Margins of Excision 01/2019 - 12/2010
2	Necrosis 01/2019 - 12/2018
2	Septic Shock (Toxic Shock Syndrome) 10/2017 - 01/2016
2	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 01/2017 - 12/2015
2	Anemia 01/2017 - 02/2005
2	Endometrial Neoplasms (Endometrial Cancer) 01/2017 - 01/2016
2	Rectal Neoplasms (Rectal Cancer) 09/2013 - 02/2008
2	HIV Infections (HIV Infection) 03/2006 - 07/2002
1	Cross Infection (Nosocomial Infection) 03/2024
1	Pulmonary Fibrosis (Fibrosing Alveolitis) 12/2023
1	Idiopathic Pulmonary Fibrosis 12/2023
1	Rupture 06/2023
1	Intraoperative Complications 06/2023
1	Carcinogenesis 01/2023
1	Pneumothorax 01/2023
1	Sialadenitis 01/2023
1	Hemothorax 01/2023
1	Obstructive Sleep Apnea 01/2023
1	Stillbirth 01/2023
1	Xerostomia 01/2023
1	Ulcerative Colitis 01/2020
1	Uterine Cervical Neoplasms (Cancer of the Cervix) 01/2020
1	Gram-Negative Bacterial Infections 01/2019
1	Radiation Pneumonitis 06/2017
1	Carcinosarcoma 01/2017
1	Proctitis 01/2017
1	Hepatocellular Carcinoma (Hepatoma) 01/2017

Drug/Important Bio-Agent (IBA)

5	Anti-Bacterial Agents (Antibiotics)IBA 11/2019 - 01/2016
4	Carbapenems (Carbapenem Antibiotics)IBA 03/2024 - 01/2019
4	AndrogensIBA 01/2022 - 08/2014
3	VaccinesIBA 01/2020 - 04/2004
3	LipidsIBA 05/2015 - 05/2008
3	EmulsionsIBA 05/2015 - 03/2009
2	Colistin (Coly-Mycin)FDA Link 12/2020 - 01/2019
2	Meropenem (Merrem)FDA LinkGeneric 12/2020 - 01/2019
2	Phenobarbital (Luminal)FDA Link 08/2019 - 01/2019
2	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2016 - 12/2014
2	Bupivacaine (Bupivacaine Hydrochloride)FDA LinkGeneric 03/2009 - 05/2008
2	Epinephrine (Adrenaline)FDA LinkGeneric 03/2009 - 05/2008
2	Glucose (Dextrose)FDA LinkGeneric 01/2009 - 07/2002
1	Biomarkers (Surrogate Marker)IBA 12/2023
1	CarcinogensIBA 01/2023
1	Urethane (Ethyl Carbamate)IBA 01/2023
1	Virus ReceptorsIBA 01/2023
1	Type A Botulinum Toxins (Botox)FDA Link 01/2023
1	4-O-carboxymethylascochlorinIBA 01/2022
1	Capsules (Microcapsules)IBA 09/2021
1	Ustekinumab (CNTO 1275)FDA Link 01/2020
1	Oncogene Proteins (Oncogene Protein)IBA 01/2020
1	C-Reactive ProteinIBA 01/2020
1	DNA (Deoxyribonucleic Acid)IBA 01/2020
1	MEDI0457IBA 01/2020
1	Infliximab (Remicade)FDA Link 11/2019
1	Immunologic Factors (Immunomodulators)IBA 11/2019
1	Tumor Necrosis Factor InhibitorsIBA 11/2019
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 11/2019
1	vedolizumabIBA 04/2018
1	Norepinephrine (Noradrenaline)FDA LinkGeneric 10/2017
1	Cisplatin (Platino)FDA LinkGeneric 01/2017
1	Histones (Histone)IBA 01/2017
1	Cetuximab (Erbitux)FDA Link 01/2017

Therapy/Procedure

29	Therapeutics 12/2023 - 01/2005
29	Radiotherapy 01/2023 - 04/2014
8	Prostatectomy (Retropubic Prostatectomy) 01/2017 - 12/2010
7	Drug Therapy (Chemotherapy) 01/2017 - 03/2007
4	Esophagectomy 01/2017 - 02/2010
3	Adjuvant Radiotherapy 01/2019 - 01/2017
3	Hysterectomy 01/2017 - 01/2017
2	Length of Stay 06/2023 - 04/2006
2	Chest Tubes (Chest Tube) 01/2023 - 04/2013
2	Injections 01/2023 - 01/2020
2	Brachytherapy 01/2022 - 08/2016
2	Argon Plasma Coagulation 01/2017 - 04/2014
2	Neoadjuvant Therapy 08/2016 - 01/2014
2	Resuscitation 03/2009 - 05/2008
1	Operative Time 06/2023
1	Occlusal Splints 01/2023
1	Anesthesia 01/2022
1	Biological Therapy 01/2020
1	Enteral Nutrition (Feeding, Tube) 10/2017